MedicalSystem Biotechnology Co

MedicalSystem Biotechnology Co Goodwill

The Goodwill of MedicalSystem Biotechnology Co (300439.SZ) as of Nov 4, 2026 is 13.56 M CNY. In the previous year, Goodwill was 16.37 M CNY — a change of -17.19% (lower).

Goodwill

13.56 MCNY

YoY

-17.19%

Last updated:

Goodwill of MedicalSystem Biotechnology Co is 2020 13.56 M CNY. Goodwill of MedicalSystem Biotechnology Co was 2019 16.37 M CNY. It decreases by -17.19% lower compared to the previous year.

The MedicalSystem Biotechnology Co Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2016
891.14 M CNY
Jan 1, 2017
848.76 M CNY
Jan 1, 2018
836.47 M CNY
Jan 1, 2019
16.37 M CNY
Jan 1, 2020
13.56 M CNY
The MedicalSystem Biotechnology Co Goodwill history
YEARGoodwillYoY
13.56 MCNY-17.19%
16.37 MCNY-98.04%
836.47 MCNY-1.45%
848.76 MCNY-4.76%
891.14 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MedicalSystem Biotechnology Co Stock analysis

What does MedicalSystem Biotechnology Co do? MedicalSystem Biotechnology Co., Ltd. generates revenue through the research, development, and manufacturing of bio-tech pharmaceutical products. The company sells in-vitro diagnostic reagents and instruments, along with third-party medical diagnosis services and reagent raw materials. Its primary market is the domestic Chinese market, serving healthcare providers and medical institutions that require diagnostic tools and services. The firm's product portfolio includes in-vitro diagnostic reagent, in-vitro diagnostic instrument, and reagent raw materials, all contributing to its revenue streams. The company focuses on the domestic market, where it provides in-vitro diagnostic products and services to hospitals and clinics. Its diagnostic reagents and instruments are used for medical testing, while the reagent raw materials support manufacturing processes. Third-party medical diagnosis services are offered to clients seeking external testing solutions. The domestic market segment represents the core customer base for MedicalSystem Biotechnology's offerings. MedicalSystem Biotechnology Co., Ltd. operates within the bio-tech pharmaceutical sector, with revenue derived from the sale of diagnostic products and services. The company's in-vitro diagnostic reagent and instrument sales form the backbone of its business, complemented by third-party medical diagnosis services and reagent raw materials distribution. Domestic healthcare institutions are the primary buyers of these products and services, driving the company's financial performance. MedicalSystem Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedicalSystem Biotechnology Co stock

Goodwill of MedicalSystem Biotechnology Co is 13.56 M CNY in 2020.

Goodwill of MedicalSystem Biotechnology Co changed from 16.37 M CNY to 13.56 M CNY, representing a -17.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Goodwill MedicalSystem Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's MedicalSystem Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — MedicalSystem Biotechnology Co

All Key Metrics — MedicalSystem Biotechnology Co